Clinical Trial Update: Tenofovir Combination or Mono-therapy for MDR CHB

View source ↗

Summary

Clinical trial update evaluating tenofovir, either in combination therapy or as monotherapy, for multidrug-resistant chronic hepatitis B; the current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Korea University | Conditions: Chronic Hepatitis b With Multidrug Resistance | Status: UNKNOWN